Evaluation of the patient for cosmetic Botox injections

Facial Plastic Surgery Clinics of North America

Volumn 11, Issue 3, 2003, Pages 349-358

  Dayan, Steven H ^a   Bassichis, Benjamin A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; APRACLONIDINE; BOTULINUM TOXIN A; NAPHAZOLINE;

ARTICLE; CLINICAL PRACTICE; DIPLOPIA; DISEASE EXACERBATION; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; DRY EYE; DYSPHAGIA; ECTROPION; ESTHETIC SURGERY; EXTRAOCULAR MUSCLE; FACE ASYMMETRY; FACE MUSCLE; FACE SURGERY; HUMAN; HYPERSALIVATION; LARYNX DISORDER; MEDICAL ASSESSMENT; PARALYSIS; PATIENT ATTITUDE; PATIENT SATISFACTION; PTOSIS; SPEECH DISORDER; TREATMENT OUTCOME; VOCAL CORD PARALYSIS;

EID: 0042475718     PISSN: 10647406     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1064-7406(03)00022-1     Document Type: Review

References (18)

1. Carruthers A, Carruthers J. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin. Dermatol Surg 1998;24:1189-94.
2. Guerrissi J, Sarkissian P. Local injection into mimetic muscles of botulinum toxin A for the treatment of facial lines. Ann Plast Surg 1997;39:447-53.
3. Blitzer A, Binder WJ, Aviv JE, et al. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg 1997;123: 389-92.
4. Fagien S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use in facial aesthetic surgery. Plast Reconstr Surg 1999;103: 701-13.
5. Matarasso SL, Matarasso A. Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytids. Plast Reconstr Surg 2001; 108:208-14; discussion 215-7.
6. Pribitkin EA, Greco TM, Goode RL, et al. Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection. Arch Otolaryngol Head Neck Surg 1997;123:321-6.
7. Wieder JM, Moy RL. Understanding botulinum toxin. Surgical anatomy of the frown, forehead, and periocular region. Dermatol Surg 1998;24:1172-4.
8. Edelstein C, Shorr N, Jacobs J, et al. Oculoplastic experience with the cosmetic use of botulinum A exotoxin. Dermatol Surg 1998;24:1208-12.
9. Carruthers JA, Lowe NJ, Menter MA, et al. A multi-center, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002;46:840-9.
10. Spencer JM, Gordon M, Goldberg DJ. Botulinum B treatment of the glabellar and frontalis regions: a dose response analysis. J Cosmet Laser Ther 2002;4:19-23.
11. Frankel AS. Botox for rejuvenation of the periorbital region. Facial Plast Surg 1999;15:255-62.
12. Klein AN. Cosmetic therapy with botulinum toxin. Dermatol Surg 1996;22:757-9.
13. Flynn TC, Carruthers JA, Carruthers JA. Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye. Dermatol Surg 2001; 27:703-8.
14. Ahn MS, Catten M, Maas CS. Temporal brow lift using botulinum toxin A. Plast Reconstr Surg 2000;105: 1129-35; discussion 1136-9.
15. Huilgo SC, Carruthers A, Carruthers JD. Raising eyebrows with botulinum toxin. Dermatol Surg 1999;25: 373-5; discussion 376.
16. Sposito MM. New indications for botulinum toxin type A in treating facial wrinkles of the mouth and neck. Aesthetic Plast Surg 2002;26:89-98.
17. Papel ID, Capone RB. Botulinum toxin A for mentalis muscle dysfunction. Arch Facial Plast Surg 2001;3: 268-9.
18. Carruthers J, Carruthers A. BOTOX use in the mid and lower face and neck. Semin Cutan Med Surg 2001;20: 85-92.